High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke.
about
High sensitivity C-reactive protein (hsCRP) & cardiovascular disease: An Indian perspective.Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patientsThe vascular effects of infection in Pediatric Stroke (VIPS) Study.Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the 'Bergen stroke study'.Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literatureDietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery disease.Lipoprotein-associated phospholipase A2 activity and risk of recurrent strokeC-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke studyHigh-sensitivity C-reactive protein, lipoprotein-related phospholipase A2, and acute ischemic stroke.The Levels of Inflammatory Markers in the Treatment of Stroke study (LIMITS): inflammatory biomarkers as risk predictors after lacunar stroke.Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection.Inflammatory mechanisms of stroke.Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study.Taiwanese female vegetarians have lower lipoprotein-associated phospholipase A2 compared with omnivores.What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseases.Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target.Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk.Inflammatory biomarkers of vascular risk as correlates of leukoariosis.Lipoprotein-associated phospholipase A2 as a predictive biomarker of sub-clinical inflammation in cardiovascular diseases.Association of C-reactive protein with cognitive impairment.Brain natriuretic peptide predicts functional outcome in ischemic strokeSystematic Review of the Association between Lipoprotein-Associated Phospholipase A2 and AtherosclerosisChinese Herb Astragalus membranaceus Enhances Recovery of Hemorrhagic Stroke: Double-Blind, Placebo-Controlled, Randomized Study.Low ficolin-3 levels in early follow-up serum samples are associated with the severity and unfavorable outcome of acute ischemic strokeA cross sectional study of anemia and iron deficiency as risk factors for arsenic-induced skin lesions in Bangladeshi women.Plasma C-Reactive Protein and Clinical Outcomes after Acute Ischemic Stroke: A Prospective Observational Study.Association of Lp-PLA2-A and early recurrence of vascular events after TIA and minor stroke.Biomarkers and mortality after transient ischemic attack and minor ischemic stroke: population-based study.Influence of race and sex on lipoprotein-associated phospholipase A2 levels: observations from the Dallas Heart Study.Predictive value of circulating interleukin-6 and heart-type fatty acid binding protein for three months clinical outcome in acute cerebral infarction: multiple blood markers profiling study.Predicting the risk of cardiovascular disease: where does lipoprotein-associated phospholipase A(2) fit in?Lipoprotein-associated phospholipase A(2) : review of its role as a marker and a potential participant in coronary endothelial dysfunction.The Relationship between C-Reactive Protein Level and Discharge Outcome in Patients with Acute Ischemic Stroke.Plasma lipoprotein-associated phospholipase A2 levels in heart failure: association with mortality in the community.Is there a correlation between hs-CRP levels and functional outcome of Ischemic Stroke?Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) studyImmune and inflammatory responses to stroke: good or bad?High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2 stability before and after stroke and myocardial infarction.Molecular mechanisms underlying application of serum procalcitonin and stool miR-637 in prognosis of acute ischemic stroke.Lipoprotein-associated phospholipase A2: a cardiovascular risk predictor and a potential therapeutic target.
P2860
Q26784205-DC4BB368-CB7A-4648-A96D-D63D798384D0Q28743387-26B64874-5B2C-4BA0-BB68-71CF1DA680F8Q30425204-8C9D439E-187D-4A06-88D3-1F815C9DE382Q33436029-BA8D03E9-9218-443B-8E08-48C53B4C2BEFQ33536648-17775B78-99FA-427C-8034-1D14593895F1Q33666216-1A49184A-68E5-4873-A57C-ADC53D891EBEQ33756465-3C878649-50F1-44AD-A22D-3011FE9AC97EQ33966178-A0C47DE4-D428-4487-8A5E-DA2947C77A94Q34036010-FE9292ED-8196-41B1-8019-68B845E6ECE8Q34054032-134A9F20-AE29-4FEC-901C-1A159F85C350Q34214336-68D752B7-D9CC-48F0-84B8-866E6F3EE886Q34235537-87646D80-C227-40B6-9891-10DC8788A55FQ34469067-2463CD47-CBC2-43AF-9FC2-2C16EDF3991FQ34474519-1EB74267-B203-4621-A0F7-E16DE16DE052Q34619162-70276DA1-07AD-4332-8D3D-1BE1DC34C73EQ34692452-B5F789F2-88C9-4F21-9684-8C693D5411AEQ34890672-39522DE5-1EB3-4253-BDA4-0944A744A127Q35045118-B9EEAC55-B988-49FB-932E-1FC0AC7784D1Q35146962-21510384-0B25-4248-8404-ED262E9CFC7FQ35591752-04099B72-1338-461A-9EA0-A23ACE9ADCFCQ35693427-C0F2C18A-3172-4330-A7E5-23DAF197C9D9Q35764402-5391B7AF-96C2-413B-AE17-E798E59920A6Q35845984-46348F68-42EA-41EC-BAFB-335976C57480Q35857874-C97864D0-C67C-4271-9414-7B677825BBE2Q35924604-F5F2DE04-1BB1-4997-91C0-D1BDAD35D827Q36039591-49A272E7-1780-4CCB-896A-9DA15F50DDBCQ36272238-BB00C62C-A157-4C8E-8CCF-541A079A120BQ36763168-FAE2C6CE-38EE-4E20-AA3A-4BE733A7C74DQ36808689-8F6ABA9B-E2AF-4BEF-BB0A-E710B52B97B3Q36902376-97BC13BE-2744-49DC-BCF0-96C47216FBA5Q36913018-3654D437-7342-4D00-9948-2E62831206FDQ36913022-37BF09B3-560E-4F65-911B-EFF053B745E0Q37128751-0FF0C298-A14C-4474-9FE3-65AA6CE17108Q37210477-F5C6E320-F66B-42F0-AD62-5B6A295A7D9FQ37257702-7DB44EA3-31EC-4D5F-B7B4-B23096C61035Q37264593-92CA13F8-2574-45BF-A706-0AE1259D6DB2Q37277232-2A49DA3F-2CD1-4573-BA89-C92E81858A1BQ37386842-1657A34C-BC59-4F5E-995B-4476EF383F7CQ37393419-42574826-2800-4785-949E-433BF5835EF2Q37445865-A4D23646-4101-4A3A-897E-8E56F7E17184
P2860
High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
High-sensitivity C-reactive pr ...... outcome after ischemic stroke.
@en
High-sensitivity C-reactive pr ...... outcome after ischemic stroke.
@nl
type
label
High-sensitivity C-reactive pr ...... outcome after ischemic stroke.
@en
High-sensitivity C-reactive pr ...... outcome after ischemic stroke.
@nl
prefLabel
High-sensitivity C-reactive pr ...... outcome after ischemic stroke.
@en
High-sensitivity C-reactive pr ...... outcome after ischemic stroke.
@nl
P2093
P1476
High-sensitivity C-reactive pr ...... outcome after ischemic stroke.
@en
P2093
Kristen Coates
Mitchell S V Elkind
Myunghee C Paik
Wanling Tai
P304
P356
10.1001/ARCHINTE.166.19.2073
P407
P577
2006-10-01T00:00:00Z